(INNS)
BUDOPRUTUG(INND)
BUDOPRUTUG(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS CD19 (B LYMPHOCYTE SURFACE ANTIGEN B4, LEU-12)], MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-450) [VH MUSMUS/HOMSAP (MUS MUSCULUS IGHV1-69*02(85.7%) -(IGHD) -IGHJ4*01 (100%)/HOMO SAPIENS IGHV1-46*01 (67.3%) -(IGHD) - IGHJ4*01 (92.3%) L123>S (115), CDR-IMGT [8.8.13] (26- 33.51-58.97-109)) (1-120) -HOMO SAPIENS IGHG1*03 (100%), G1M3, NG1M1 CH1 R120, E12, M14 (CH1 R120 (217) (121- 218), HINGE 1-15 (219-233), CH2 (234-343), CH3 E12 (359), M14 (361) (344-448), CHS (449-450)) (121-450)], (223-211')- DISULFIDE WITH KAPPA LIGHT CHAIN (1'-211') [V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV4-70*01 (90.3%) - IGKJ1*01 (100%)/HOMO SAPIENS IGKV3D-11*01 (63.8%) - IGKJ4*01 (90.9%) V124>L (101'), CDR-IMGT [5.3.7] (27'- 31'.49'-51'.88'-94')) (1'-104') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (150'), V101 (188') (105'-211')]; DIMER (229- 229'':232-232'')-BISDISULFIDE, PRODUCED IN YB2/0 CELL LINE, GLYCOFORM ALFA(WHO)
BUDOPRUTUGUM(INN)